-
The Finance Committee found that the TCJA enabled some of the biggest to lower their tax bills by shifting profits abroad.
May 12 -
The Top 10 Firm will be adding 14 full-time AdaptaLogix professionals to its digital team.
November 1 -
The Senate Finance chairman is investigating the embattled drugmaker and formula producer’s low tax rates, alleging the company’s investments in stock buybacks may have driven the nationwide formula shortage.
May 18 -
Sen. Ron Wyden has questions about why the company consistently loses money in the U.S. and doesn’t pay more in taxes.
June 3 -
The Justice Department investigation into the allergy shot would eventually cost the drug maker nearly $500 million.
September 27 -
The Democratic presidential candidate rolled out a policy blueprint to slash prescription prices when they cost less in other developed countries.
July 16 -
One of China’s largest listed drug makers said related parties used the firm’s funds to trade its shares, a day after the securities regulator alleged financial data had been fabricated.
May 20 -
Now that Republicans in Congress have released their final tax bill, two big questions remain. What will companies do with all that cash, and who will benefit the most?
December 18